HIFU vs. Cryotherapy for skin cancer and Bowen's disease
Part of Cancer clinical trials.
This trial compares two treatments for certain types of skin cancer (basal cell carcinoma) and a very early skin cancer called Bowen's disease. One treatment uses high-intensity focused ultrasound (HIFU) and the other uses freezing (cryotherapy). It aims to find out which works better for lesions on the body, from the neck down to the knees.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- Your skin lesion is located between your neck and knees (not on your face, head, genitals, hands, or below your knee)
- You have a confirmed diagnosis of a specific type of skin cancer: superficial BCC (up to 2 cm across), nodular BCC (up to 1.5 cm across), or Bowen's disease (up to 2 cm across)
- Your cancer is not considered high-risk or aggressive
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether 5-fluorouracil and calcipotriene (medicines used on the skin) can treat certain small, early skin cancers or pre-cancers without surgery. It’s for specific types and locations of lesions and aims to see how well the treatment works and how safe it is.
This study tests an experimental drug called FLD-103 injected into a specific type of skin cancer (nodular basal cell carcinoma) that hasn't been treated before. The goal is to see if it helps remove the cancer before final surgery.
This Phase 1/2 trial tests EscharEx (an investigational treatment) to see if it is safe and works on a single small basal cell skin cancer on the trunk or upper arms. You might qualify if your cancer fits specific size and location rules and you have not had radiation to that spot.
This trial is testing whether freezing (cryotherapy) or using high-frequency ultrasound (HIFU) to destroy only the cancer spots in the prostate is safe and effective for men with early-stage prostate cancer. It's a less invasive option that targets just the tumor, not the whole prostate.
This trial tests a combination of blue-light therapy (a type of photodynamic therapy) and an oral medication called sonidegib for people with multiple basal cell carcinomas (BCCs). It may be an option if you have several BCCs that are not suitable for surgery or radiation, or if you prefer not to have surgery.
This trial tests a new treatment that combines light (photodynamic therapy) and sound (sonodynamic therapy) to treat a common type of skin cancer called nodular basal cell carcinoma. The goal is to see if this combination works better than light alone for small tumors.
Hear when a new Superficial Basal Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.